… Author links open overlay panel Maurizio Giuseppe Abrignani a , Luigi Gatta c , Domenico
Gabrielli d , Giuseppe Milazzo e , Vincenzo De Francesco f , Leonardo De Luca g , Maura …

Classical risk factors only partially account for variations in cardiovascular disease incidence;
therefore, also other so far unknown features, among which meteorological factors, may …

Pathology studies demonstrated that coronary fatty streaks develop early in life and that even
more advanced fibrous plaques are present in a proportion of adolescents. The presence …

Cardiovascular diseases (CVD) have a lower prevalence in women than men; although, a
higher mortality rate and a poorer prognosis are more common in women. However, there is a …

Aspirin, other antiplatelet agents, and anticoagulant drugs are used across a wide spectrum
of cardiovascular and cerebrovascular diseases. A concomitant proton pump inhibitor (PPI) …

It is well established that direct oral anticoagulants (DOACs) are the cornerstone of anticoagulant
strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and should be …

The global population is experiencing an aging trend; however, this increased longevity is
not necessarily accompanied by improved health in older age. A significant consequence of …

Chronic coronary syndrome (CCS), which encompasses a broad spectrum of clinical
presentations of coronary artery disease (CAD), is the leading cause of morbidity and mortality …

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y 12 receptor inhibitor is the cornerstone
of pharmacologic management of patients with acute coronary syndrome (ACS) and/or …

It has been consistently demonstrated that circulating lipids and particularly low-density
lipoprotein cholesterol (LDL-C) play a significant role in the development of coronary artery …